Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Intro slide
- The RB pathway in human cancer
- E2F responsive genes & timing of expression
- Cell cycle regulation of a single promoter by E2F
- E2F family members
- E2F family members activator E2Fs
- E2F family members repressor E2Fs
- Pocket protein family members
- E2F-RB family interactions
- Chromatin immunoprecipitation (ChIP) strategy
- E2F & pRB families: promoter occupancy
- Histone acetylation parallels activation of E2F
- HDAC binding during G0
- HDAC recruitment in primary cells
- E2F4/Sin3/HDAC promoter binding
- E2F drives the transcriptional cycle
- Cell cycle re-entry
- Location analysis (ChIP on chip)
- Repressor & activator E2F target genes overlap
- Gene expression networks
- Multiple targets de-regulated by p107/p130 loss
- Distinct growth arrest conditions
- Genes repressed upon cell cycle exit
- Binding by E2F4 & p130: statistical correlations
- p130-E2F4 represses a core set of genes
- Over-expression of genes in primary tumors
- Distinct growth arrest conditions
- Identifying factors that cooperate with E2F
- NRF1 binding to E2F responsive promoters
- Knocking down a factor
- How E2F controls the cell cycle
- The cell cycle arrest network module
- pRB family recruited to promoters in cycling cells
- RB chIP on chip analysis
- Distinct roles for the pRB family on chromatin
- FACS analysis and western blot
- E2F & pocket proteins roles
- A histone acetylation/de-acetylation cycle
- p107, p130, and E2F4: overlapping
- E2F chIP on chip analysis
- Expression analysis defines classes of E2F target
- Sin3B marks promoters for repression in early G1
- Promoter-specific de-acetylation
- E2F drives the transcriptional cycle
- Repressor E2F networks
- E2F and RB and tumor suppression
- E2F and apoptosis
- Acknowledgements
Topics Covered
- Complex and diverse roles of E2F family members
- Interaction with tumour repressor proteins
- Interaction with chromatin modifying enzymes
- Study using microarray technology and chromatin immunoprecipitation
- Novel features of cell cycle dependent transcription
- Roles in regulating G1-to-S transition, mitosis, differentiation, and apoptosis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Dynlacht, B. (2007, October 1). The E2F family and transcriptional control of the mammalian cell cycle [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/NDKO9772.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Brian Dynlacht has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The E2F family and transcriptional control of the mammalian cell cycle
A selection of talks on Oncology
Hide